Covered recipient · General Payments record
RYAN T HUNLEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,712.39
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $270.66 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $80.26 | 5 |
| Novo Nordisk AS | $49.46 | 3 |
| Amgen Inc. | $33.49 | 2 |
| Acerta Pharma LLC | $31.17 | 2 |
| Daiichi Sankyo Inc. | $21.86 | 1 |
| Lilly USA, LLC | $21.59 | 1 |
| GlaxoSmithKline, LLC. | $19.05 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.99 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103954872 | CMS |
| ABBVIE INC. | $16.68 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103954874 | CMS |
| ABBVIE INC. | $17.86 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103954876 | CMS |
| ABBVIE INC. | $18.24 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103954878 | CMS |
| ABBVIE INC. | $13.49 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103954880 | CMS |
| Amgen Inc. | $17.84 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115741455 | CMS |
| Amgen Inc. | $15.65 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115741464 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.74 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104744819 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.43 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105665168 | CMS |
| Daiichi Sankyo Inc. | $21.86 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089435600 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.78 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101785251 | CMS |
| GlaxoSmithKline, LLC. | $19.05 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116321375 | CMS |
| Lilly USA, LLC | $21.59 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135408817 | CMS |
| Novo Nordisk Inc | $13.70 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900769 | CMS |
| Novo Nordisk Inc | $13.10 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097699843 | CMS |
| Novo Nordisk Inc | $22.66 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096851419 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.